Literature DB >> 25955458

The Surviving Sepsis Campaign: Where have we been and where are we going?

R Phillip Dellinger1,2,3.   

Abstract

The Surviving Sepsis Campaign develops and promotes evidence-based guidelines and performance-improvement practices aimed at reducing deaths from sepsis worldwide. The most recent guidelines, published in 2013, provide detailed management strategies for acute care, fluid resuscitation, and vasopressor use. In addition, the campaign has developed simple, short protocols for what to do within 3 and 6 hours of recognition of sepsis. These protocols are associated with reduced mortality rates.
Copyright © 2015 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955458     DOI: 10.3949/ccjm.82gr.15001

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  10 in total

Review 1.  [Updated definition of sepsis : Implications for diagnostics and therapy principles].

Authors:  N Schlegel
Journal:  Chirurg       Date:  2017-01       Impact factor: 0.955

2.  SOFA score and left ventricular systolic function as predictors of short-term outcome in patients with sepsis.

Authors:  Francesca Innocenti; Vittorio Palmieri; Aurelia Guzzo; Valerio Teodoro Stefanone; Chiara Donnini; Riccardo Pini
Journal:  Intern Emerg Med       Date:  2016-12-01       Impact factor: 3.397

3.  Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study.

Authors:  Asim Ahmed; Sayed A Alderazi; Rumaisa Aslam; Barooq Barkat; Bethan L Barker; Rahul Bhat; Samuel Cassidy; Louise E Crowley; Davinder Ps Dosanjh; Hussain Ebrahim; Najla Elndari; Claudia Gardiner; Atena Gogokhia; Frances S Grudzinska; Megha T Gurung; Terry Hughes; Iyad Ismail; Natasha Iredale; Sannaan Irshad; Sarah Johnson; Diana Kavanagh; Thomas Knight; Alana Livesey; Sebastian T Lugg; Manoj Marathe; Andrew McDougall; Wasim Nawaz; Kimberly Nettleton; Lauren O'Flynn; Kelvin Okoth; Dhruv Parekh; Rita Perry; Elizabeth J Pudney; Ambreen Sadiq; Olutobi Soge; Rhania Soloman; Marina Soltan; Martin Strecker; Onn S Thein; David Thickett; Ajit Thomas; Riah Thornton
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

Review 4.  The Use of Fluids in Sepsis.

Authors:  Audrey A Avila; Eliezer C Kinberg; Nomi K Sherwin; Robinson D Taylor
Journal:  Cureus       Date:  2016-03-10

5.  Epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain.

Authors:  Alejandro Álvaro-Meca; María A Jiménez-Sousa; Dariela Micheloud; Ainhoa Sánchez-Lopez; María Heredia-Rodríguez; Eduardo Tamayo; Salvador Resino
Journal:  Popul Health Metr       Date:  2018-02-12

6.  MALDI-TOF MS monitoring of PBMC activation status in sepsis.

Authors:  Aurélie Daumas; Julie Alingrin; Richard Ouedraogo; Patrick Villani; Marc Leone; Jean-Louis Mege
Journal:  BMC Infect Dis       Date:  2018-07-31       Impact factor: 3.090

7.  Appropriate empirical antibiotic therapy and mortality: Conflicting data explained by residual confounding.

Authors:  Romy Schuttevaer; Jelmer Alsma; Anniek Brink; Willian van Dijk; Jurriaan E M de Steenwinkel; Hester F Lingsma; Damian C Melles; Stephanie C E Schuit
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

8.  Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsis.

Authors:  Gernot Marx; Kai Zacharowski; Carole Ichai; Karim Asehnoune; Vladimír Černý; Rolf Dembinski; Ricard Ferrer Roca; Dietmar Fries; Zsolt Molnar; Peter Rosenberger; Manuel Sanchez-Sanchez; Tobias Schürholz; Tamara Dehnhardt; Sonja Schmier; Elke von Kleist; Ute Brauer; Tim-Philipp Simon
Journal:  Trials       Date:  2021-06-02       Impact factor: 2.279

9.  Association of Health Insurance Status with Outcomes of Sepsis in Adult Patients: A Retrospective Cohort Study.

Authors:  Gaon-Sorae Wang; Kyoung-Min You; You-Hwan Jo; Hui-Jai Lee; Jong-Hwan Shin; Yoon-Sun Jung; Ji-Eun Hwang
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 3.390

10.  Qiang-Xin 1 Formula Prevents Sepsis-Induced Apoptosis in Murine Cardiomyocytes by Suppressing Endoplasmic Reticulum- and Mitochondria-Associated Pathways.

Authors:  Xiaolong Xu; Qingquan Liu; Shasha He; Jingxia Zhao; Ning Wang; Xuyang Han; Yuhong Guo
Journal:  Front Pharmacol       Date:  2018-07-30       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.